Kenneth L. Londoner - 07 Jun 2021 Form 4/A - Amendment Insider Report for BioSig Technologies, Inc. (BSGM)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Kenneth L. Londoner, attorney-in-fact
Issuer symbol
BSGM
Transactions as of
07 Jun 2021
Net transactions value
+$7,130
Form type
4/A - Amendment
Filing time
03 Sep 2021, 16:55:43 UTC
Date Of Original Report
08 Jun 2021
Previous filing
03 Sep 2021
Next filing
03 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSGM Common Stock Purchase $7,130 +2,000 +0.12% $3.56* 1,673,958 07 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purpose of this Amendment is to correct the Transaction Code in column 3 of Table I, which inadvertently used Transaction Code "A" instead of "P".